Fact sheet: the north carolina hiv medications program
FACT SHEET: The North Carolina HIV Medications/AIDS Drug Assistance Program (ADAP) HIV/STD Prevention and Care Branch - Division of Public Health, NC DHHS What is the North Carolina HIV Medications Program?
The North Carolina HIV Medications Program, also referred to as the AIDS Drug Assistance Program (ADAP), uses a
combination of State and federal funds to provide low-income residents of the State with assistance in obtaining essential, life-sustaining medications to fight HIV/AIDS and the opportunistic infections which often accompany the
disease. The Program purchases the medications in bulk from a pharmaceutical wholesaler, and a central pharmacy
dispenses and sends the prescriptions for each client to the client’s designated address.
Who is eligible to participate in the Program?
In order for someone to be eligible for ADAP, the individual must:
• Have a net family income that is at or below 125% of the federal poverty level (see the back of this page for
the current FPL for various family sizes);
• Not have other third-party coverage (e.g., private insurance or Medicaid) that pays for medications; and,
• Have a (or several) prescription(s) for medications that are included in the ADAP formulary (list of drugs that the
Program will pay for) – (The medications provided under this Program are limited to those specifically related to
the diagnosis and treatment of HIV disease/AIDS - see the back of this page for the current ADAP formulary)
How does someone apply to and get into the Program?
An individual who wants to apply for ADAP coverage should talk to their clinician or the person in the office who
handles bills and/or insurance, their HIV case manager, or someone at one of NC’s HIV Care Consortia, at any
local/public health department, or at an AIDS service organization/agency. The applicant, with the assistance of these
individuals, will complete two forms; one to establish that the individual qualifies financially for the Program and one to document their HIV+ status, their need for medications provided under this Program and a mailing/delivery address
for the medications. These two forms are then sent to the Office of Purchase of Medical Care Services for a final
determination of eligibility. The individual and their “case manager” will be advised if the applicant is eligible for and if
they have been enrolled in the Program. Prescription information may either be captured on the central pharmacy’s
enrollment form and faxed to the central pharmacy or the actual prescriptions may be mailed to the central pharmacy.
These three forms, along with the POMCS provider/instruction manual can be found and downloaded at
Is there any cost to the individual?
There is no cost to the individual covered under this Program for the drugs that are on the Program’s formulary. The individual is responsible for the cost of other drugs that they receive which are not covered by the Program.
How does someone get more information about the HIV Medications Program?
For more information about the HIV Medications Program, please go to , or you may contact:
• Steve Sherman – Coordinator, NC AIDS Drug Assistance/HIV Medications Program (ADAP), HIV/STD Prevention
• Sally Kohls – Nurse Consultant, ADAP, HIV/STD Prevention and Care Branch – (919) 733-9602 or
• Purchase of Medical Care Services (applications are processed by the client’s last name alphabetically) -
• (A-D) - Toni Wallace - (919) 855-3668
• (L-P, R) - Debbie Pollard - (919) 855-3667
• (E-K) - Mike Benson - (919) 855-3666
• (Q, S-Z) - Glenys Spencer - (919) 855-3665.
[Please see the other side of this page for additional information]
Family Size / Federal Poverty Level ($) As of April 1, 2006
Note: As of January 1, 2006, NC's ADAP financial eligibility is at or below 125% of the FPL.
HIV MEDICATIONS/ADAP PROGRAM Listing of Covered Medications As of January 1, 2006 Antiretrovirals: (FDA approved) amprenavir – Agenerase delavirdine - Rescriptor tipranavir - Aptivus zidovudine (AZT) – Retrovir zidovudine and lamivudine – Combivir atazanavir – Reyataz indinavir – Crixivan efavirenz – Sustiva emtricitabine – Emtriva zidovudine, lamivudine and abacavir –Trizivir lamivudine (3TC) – Epivir tenofovir and emtricitabine – Truvada abacavir and lamivudine - Epzicom didanosine (ddI) – Videx enfuvirtide – Fuzeon * nelfinavir - Viracept zalcitibine (ddC) - Hivid nevirapine – Viramune saquinivir - Invirase, Fortovase tenofovir – Viread lopinavir/ritonavir – Kaletra stavudine (d4T) – Zerit fosamprenavir - Lexiva abacavir – Ziagen ritonavir - Norvir
* Access to Fuzeon is governed by special medical eligibility/appropriateness criteria, including a separate approved application
Other Medications: acyclovir -- Zovirax atovaquone -- Mepron azithromycin -- Zithromax clarithromycin -- Biaxin clindamycin -- Cleocin dapsone (DDS) -- Dapsone ethambutol -- Myambutol fluconazole -- Diflucan ganciclovir (DHPG) -- Cytovene hydroxyurea --Hydrea itraconozole -- Sporanox ketoconazole leucovorin nystatin -- Mycostatin, Nilstat paromomycin -- Humatin pentamidine -- NebuPent pyramethamine -- Daraprim rifabutin sulfadiazine omeprazole -- Prilosec lansoprazole -- Prevacid ondansetron hydrochloride -- Zofran prochlorperazine -- Compazine promethazine -- Phenergan loperamide -- Imodium amitriptyline -- Elavil nortriptyline -- Aventyl, Pamelor pancrelipase -- Pancreas MT-20 famciclovir -- Famvir valacyclovir -- Valtrex ciproflaxicin hydrochloride -- CIPRO diphenoxylate hydrochloride with atropine sulfate -- Lomotil sulfamethoxazole/trimethoprim (smx/tmp; tmp-smx) -- Bactrim, Septra, Cotrim, Sulfatrim valganciclovir hydrochloride -- Valcyte
Notes: (1) These are examples of brand names and not meant to be all inclusive (2) Generic medications are dispensed unless the prescription is written for a specific brand name
Decisions about what medications are included within the Program formulary are guided by an HIV Clinical/Medications Advisory Committee. Members of this Committee (clinicians, case managers, HIV program administrators, consumers and others), provide their expertise and perspectives primarily on issues related to the efficacy and importance of new medications. The also provide advice on activities related to the operation and effectiveness of the Program. Their perspectives and best thinking on these issues are integrated with considerations about budgetary status and Program/policy regulations and priorities. While final decisions with regard to all of these matters rest with the State agency responsible for administering the Program (i.e., the HIV/STD Prevention and Care Branch of the Division of Public Health, Department of Health and Human Services), the HIV Clinical/Medications Advisory Committee plays an invaluable role in assuring that “real world” experience and expertise are incorporated into the decisions made by and operation of the Program.
[Please see the other side of this page for additional information]
PRACTICAL CLINICAL COURSES CLINICAL TIPS FOR HYGIENISTS – FROM DENTISTS Materials Included Gordon J. Christensen PRACTICAL CLINICAL COURSES PROCEDURE FOR RECEIVING ACADEMY OF GENERAL DENTISTRY AND STATE CREDIT Complete the enclosed Post Test. If more than one person needs to take the test, please feel free to make additional copies. However, only 2 free tests are
TouchProbe ® The Next Generation in Data Collection TouchProbe offers a completely new and powerful way of collecting and managing your data. With a simple contact, you can now access informationfrom touch “buttons.” These “buttons” are memorychips housed in small, water-resistant, stainless steelcases. The buttons work like electronic labels thatthe TouchProbe uses for the